Hoth Reports Positive Preclinical Results For HT-KIT
12/5 16:25
(RTTNews) - Hoth Therapeutics, Inc. (HOTH), a patient-focused biopharmaceutical company developing innovative therapies for unmet medical needs, Monday announced compelling preclinical data for HT-KIT, its proprietary antisense oligonucleotide (ASO) therapeutic designed to target...